Jove
Visualize
Contact Us

Related Experiment Videos

Additional arrows for the beta-amyloid target.

B Cordell1

  • 1California Biotechnology, Inc., Mountain View 94043.

Neurobiology of Aging
|September 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of β-Amyloid Peptide Degradation In Vitro.

Methods in molecular medicine·2011
Same author

Neuronal DNA damage correlates with overexpression of interleukin-1beta converting enzyme in APPV717F mice.

Neurobiology of aging·2002
Same author

Specific spatial learning deficits become severe with age in beta -amyloid precursor protein transgenic mice that harbor diffuse beta -amyloid deposits but do not form plaques.

Proceedings of the National Academy of Sciences of the United States of America·2001
Same author

Novel functional assay for proteases and modulators. Application in beta-secretase studies.

Molecular biotechnology·2001
Same author

Glycogen synthase kinase-3beta regulates presenilin 1 C-terminal fragment levels.

The Journal of biological chemistry·2001
Same author

Conversion of brain apolipoprotein E to an insoluble form in a mouse model of Alzheimer disease.

Neuroreport·2001
Same journal

Amygdala and hippocampal volumes as neural correlates of resilience and loneliness in older adults.

Neurobiology of aging·2026
Same journal

Hippocampal-cortical structural networks in the progression of cognitive impairment: A source-based morphometry analysis in individuals with subjective cognitive decline, mild cognitive impairment and Alzheimer's disease.

Neurobiology of aging·2026
Same journal

Brain structure in the cingulate cortex and locus coeruleus in late life is associated with engagement in complex mental activities across the life span.

Neurobiology of aging·2026
Same journal

Age-related differences in motor learning, sensorimotor neurochemistry, and cortical reactivity co-occur but are dissociated.

Neurobiology of aging·2026
Same journal

How cognition and hearing-related measures covary with hippocampal subfield features from structural MRI in younger and older adults.

Neurobiology of aging·2026
Same journal

Decreased awareness of cognitive decline is associated with multimodal Alzheimer's disease biomarkers in cognitively unimpaired individuals.

Neurobiology of aging·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Researchers are investigating beta-amyloid production mechanisms to find new Alzheimer's disease therapies. Understanding how beta-amyloid forms is key to identifying effective therapeutic targets.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Alzheimer's disease is characterized by the accumulation of beta-amyloid plaques in the brain.
  • The precise molecular mechanisms driving beta-amyloid genesis remain incompletely understood.
  • Existing molecular tools offer opportunities to experimentally validate proposed pathways.

Purpose of the Study:

  • To elucidate the specific molecular mechanisms underlying beta-amyloid production.
  • To identify and validate novel therapeutic targets for Alzheimer's disease.

Main Methods:

  • Utilizing a range of molecular biology techniques and biochemical assays.
  • Designing experiments to test various postulates of beta-amyloid genesis.
  • Employing advanced imaging and proteomic analyses.

Related Experiment Videos

Main Results:

  • Experimental data are currently being generated to differentiate between competing hypotheses.
  • Key molecular players and pathways involved in beta-amyloid formation are being identified.
  • Potential intervention points for modulating beta-amyloid levels are emerging.

Conclusions:

  • Identifying the correct mechanism of beta-amyloid genesis is crucial for developing effective Alzheimer's treatments.
  • This research aims to translate fundamental discoveries into tangible therapeutic strategies.
  • The findings will guide the development of targeted therapies to combat Alzheimer's disease progression.